Adjuvants in vaccines for human use

Current effective version

PDF iconAdopted guideline

Reference numberCHMP/VEG/134716/04
Effective from31/07/2005
KeywordsImmunomodulators, adjuvants, vaccines
DescriptionThis document addresses the quality, non-clinical and clinical issues arising from the use of new or established adjuvants in vaccines. The applicability of this guideline to established adjuvants will vary on case-by-case basis. Adjuvants that are given separately and/or at a different time point from the vaccine antigens are not considered to be adjuvants and are called immunomodulators. Read together with the PDF iconExplanatory note on immunomodulators

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconConcept paper

In operation: 31/07/2005–present

Published: 25/04/2002

Related content

How useful was this page?

Add your rating